NL-OMON35427招募中不适用
Idiopathic non-cirrhotic intrahepatic portal hypertension (INCIPH): assessment of thrombophilia and histopathology in a multicentre cohort study and HIV patients. - Idiopathic non-cirrhotic intrahepatic portal hypertension (INCIPH)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •1) Evidence of portal hypertension (oesophageal varices, hypersplenism or ascites)
- •2) Doppler ultrasound showing patent portal and hepatic veins
- •3) Liver biopsy showing no cirrhosis
- •4) Exclusion of conditions causing cirrhosis according to conventional diagnostic criteria (chronic viral hepatitis, alcoholic liver disease, NASH, obesity, hemochromatosis, autoimmune hepatitis or Wilson*s disease)
- •5) Exclusion of chronic vitam A intake, professional exposure to copper sulphate, vinyl chloride monomer, Spanish toxic oil or arsenic salts
- •6) Older than 18 years at diagnosis.
- •7) HIV patients
排除标准
- •1) Presence of cirrhosis
- •2) Presence of portal thrombosis at diagnosis
- •3) Presence of conditions causing cirrhosis according to conventional diagnostic criteria (chronic viral hepatitis, alcoholic liver disease, NASH, obesity, hemochromatosis, autoimmune hepatitis or Wilson*s disease).
- •4) Presence of chronic vitam A intake, professional exposure to copper sulphate, vinyl chloride monomer, Spanish toxic oil or arsenic salts
- •5) Younger than 18 years old at diagnosis.
- •6) intake oral anticoagulation
研究者
相似试验
进行中(未招募)
1 期
APISApixaban for Intrahepatic Non Cirrhotic Portal HypertensioIntrahepatic non-cirrhotic portal hypertensionMedDRA version: 20.1Level: PTClassification code: 10077259Term: Non-cirrhotic portal hypertension Class: 100000004871CTIS2024-514348-95-00Assistance Publique Hopitaux De Paris166
进行中(未招募)
3 期
Apixaban for Intrahepatic Non Cirrhotic Portal HypertensionIntrahepatic Non Cirrhotic Portal HypertensionNCT04007289Assistance Publique - Hôpitaux de Paris166
已完成
不适用
Covered transjugular intrahepatic portosystemic stent shunt versus optimised medical treatment for the secondary prevention of variceal bleeding in cirrhosisISRCTN16334693Individual sponsor (Germany)186
进行中(未招募)
不适用
Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosisliver cirrhosisesophageal (variceal) bleedingEUCTR2005-003557-27-DEDean of the Medical Faculty (University of Bonn)
尚未招募
不适用
on-Invasive Portal and Hepatic Vein Pressure Estimation: MRI-Guided Diagnostics for Chronic Liver DiseaseNL-OMON56118eids Universitair Medisch Centrum50
